arrow
F

Francesca Di Matteo

University of Salerno
H指数:9
被引数:227

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular Basis for Activation to Inhibition Switching in Kv7.2 Channel Modulators

Kv7.2通道调节剂中从激活到抑制的转换的分子机制

2026-08-280
OAAI
Targeting Cathepsins in Neurodegeneration: Biochemical Advances

靶向神经退行性疾病中的组织蛋白酶:生物化学进展

2026-03-040
OAAI
An adamantylureido-benzylamide aniline as FLAP/sEH dual inhibitor: rational design, in vitro and in vivo lipidomic profiling

adamantylureido-苄酰胺苯胺作为FLAP/sEH双抑制剂:理性设计、体外及体内脂质组学分析

2025-11-030
PRE
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening; Bioinformatics; and Omics for Target Deconvolution

靶向多样性导向合成用于抗癌新药发现:一种整合反向虚拟筛选、生物信息学和组学技术进行靶点解卷积的综合方法

2025-07-240
OA
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization

新型对苯二胺基衍生物作为受体酪氨酸激酶样孤寡受体1(ROR1)抑制剂:体外初步表征

2025-06-010
PREAI
A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors
2024-07-221
PRE
KCNT1 Channel Blockers: A Medicinal Chemistry Perspective

KCNT1通道阻滞剂: 药物化学观点

2024-06-202
OAAI
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel
2024-05-235
OAAI
Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone
2024-04-014
OAAI
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization
2024-02-016
OAAI
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis
2023-06-198
OAAI
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization
2022-11-0117
OAAI
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models
2022-08-0116
PRE
Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization
2021-12-0128
OAAI